Lead Product(s): Hydrocortisone
Therapeutic Area: Endocrinology Product Name: ZENEO Hydrocortisone
Highest Development Status: Undisclosed Product Type: Small molecule
Deal Size: $11.0 million Upfront Cash: Undisclosed
Deal Type: Licensing Agreement June 15, 2021
The ready to use ZENEO® Hydrocortisone will provide a 2-step rescue kit developed for a simple and intuitive autoinjection even by non healthcare professionals.
Lead Product(s): Undisclosed
Therapeutic Area: Endocrinology Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Peptide
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement July 29, 2020
The partnership includes a basket of difficult-to-make peptide products that will be used to treat various diseases, ranging from diabetes to immunology disorders, cardiologic and endocrinology diseases.